Brief: Theranexus Announces Preliminary Results Of Phase II Trial Of THN102

Thx Pharma SA

27/02/2019 17:19

Feb 27 (Reuters) - THERANEXUS SA  ALTHX.PA :
    * THERANEXUS ANNOUNCES PRELIMINARY RESULTS OF PHASE II TRIAL
OF
THN102 ON NARCOLEPSY PATIENTS
    * THERANEXUS WILL CONTINUE TO EXAMINE TRIAL DATA WITH A VIEW
TO
EVALUATING CLINICAL PROFILE OF THN102
    * THN102'S SAFETY AND TOLERABILITY PROFILE HAS BEEN DEEMED
VERY
SATISFACTORY
    * HOWEVER, RESULTS DO NOT INDICATE ANY DIFFERENCE IN
EFFICACY
BETWEEN THN102 AND MODAFINIL ALONE WITH RESPECT TO TRIAL'S
PRIMARY ENDPOINT (EPWORTH SLEEPINESS SCALE)

Source text for Eikon:  ID:nACT57309 
Further company coverage:  ALTHX.PA 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 09 20;))